OKYO Pharma Limited (OKYO)
1.26
0.00 (0.01%)
At close: Mar 03, 2025, 3:59 PM
1.26
0.00%
After-hours: Mar 03, 2025, 03:59 PM EST
OKYO Pharma Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | 7.51K | 3.8K | 2.42K | 13.09K | 5.97K | 219.17 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit | -7.51K | -3.8K | -2.42K | -13.09K | -5.97K | -219.17 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Income | -15.75K | -13.19M | -6.22M | -4.13M | -1.52M | -4.54M | -28.25M | -363.27K | -1.12M | -1.75M | -4.77M | -4.72M | -5.11M | -1.7M | 28.61M | 15.1M | -3.17M |
| Interest Income | n/a | n/a | n/a | n/a | 48.06K | n/a | n/a | 4.42K | 12.36K | 17.29K | n/a | 93.22K | 20.67K | 141.41K | 1.51K | 381.07K | 345.28K |
| Pretax Income | -16.8K | -13.28M | -6.22M | -3.38M | -1.62M | -4.9M | -28.27M | -241.93K | -1.01M | -1.49M | -13.93M | -4.66M | -5.7M | -1.62M | 12.67M | 14.33M | -2.97M |
| Net Income | -16.83K | -13.27M | -5.43M | -3.35M | -1.54M | -4.9M | -28.27M | -241.93K | -820.17K | -8.26M | -13.93M | -4.66M | -4.8M | -1.62M | 12.67M | 14.33M | -2.97M |
| Selling & General & Admin | n/a | 6.75M | 4.93M | 2.97M | 995.42K | 1.85M | 573.43K | 363.2K | 1.05M | 1.74M | 4.61M | 4.67M | n/a | 1.61K | 4.52K | 63.03K | 73.42K |
| Research & Development | 8.24K | 6.34M | 1.61M | 348.35K | 517.46K | 3.04M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Expenses | n/a | n/a | n/a | n/a | n/a | -15.81K | -12.43K | 116.92K | 48.57K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Expenses | 8.24K | 13.19M | 6.22M | 3.37M | 1.51M | 4.54M | 1.04M | 363.27K | 1.1M | 1.75M | 4.77M | 4.73M | 5.41M | 1.7M | -20.6M | -15.1M | 3.17M |
| Interest Expense | 1.05M | 96.69K | n/a | 1.12K | 1.16K | n/a | n/a | n/a | n/a | n/a | 4.14K | n/a | n/a | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.61K | 4.52K | 63.03K | 73.42K |
| Cost & Expenses | 15.75K | 13.19M | 6.22M | 3.37M | 1.52M | 4.54M | 1.04M | 363.27K | 1.1M | 1.75M | 4.77M | 4.73M | 5.41M | 1.7M | -20.6M | -15.1M | 3.17M |
| Income Tax | 22.42 | -12.2K | -786.52K | -24.99K | -76.19K | -171.64K | 0.83 | -56.94K | -189.99K | 6.76M | 4.14K | 0.02 | -895.15K | n/a | n/a | n/a | n/a |
| Shares Outstanding (Basic) | 29.34M | 22.26M | 979.21M | 672.77M | 595.47M | 513.9M | 382.88M | 381.16M | 381.16M | 377.12M | 300.92M | 283.16M | 258.95M | 355.1M | 330.76M | 326.83M | 55.69M |
| Shares Outstanding (Diluted) | 29.34M | 22.26M | 979.21M | 672.77M | 595.47M | 513.9M | 382.88M | 381.16M | 381.16M | 377.12M | 300.92M | 283.16M | 258.95M | 355.1M | 355M | 351.09M | 55.69M |
| EPS (Basic) | -0.00 | -0.6 | -0.01 | -0.01 | -0.00 | -0.01 | -0.07 | -0.00 | -0.00 | -0.02 | -0.05 | -0.02 | -0.02 | -0.00 | 0.04 | 0.04 | -0.05 |
| EPS (Diluted) | -0.00 | -0.6 | -0.01 | -0.01 | -0.00 | -0.01 | -0.07 | -0.00 | -0.00 | -0.02 | -0.05 | -0.02 | -0.02 | -0.00 | 0.04 | 0.04 | -0.05 |
| EBITDA | -15.75K | -13.18M | -6.22M | -3.35M | -1.51M | -4.54M | 26.17M | -363.27K | -1.12M | -1.75M | -4.67M | -4.7M | -5.09M | -1.7M | 28.61M | 15.1M | -3.17M |
| Depreciation & Amortization | 3.87K | 3.8K | 2.33K | 13.11K | 5.97K | 217.82 | 104.61M | 52.52K | -18.71K | n/a | 103.44K | 24.44K | 19.61K | n/a | n/a | n/a | n/a |